Dr. Abdullah Mohamad Qatu, MD

Dr. Qatu practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Qatu's NPI, 1922503648, was assigned on March 26, 2018. Dr. Qatu graduated from New York University School of Medicine in 2017. Dr. Qatu holds California license A176773.

Dr. Qatu's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Qatu's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Qatu is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Qatu to 2 more hospitals, each named with a free account. Dr. Qatu's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Qatu practices, 4 sites in all. Vendor and product names are available with a free account.

Pain medicine is Dr. Qatu's primary specialty in the NPI Registry, under taxonomy code 208VP0000X. The record also lists pain medicine. Dr. Qatu is board certified in anesthesiology by the American Board of Anesthesiology. Dmand AI has Dr. Qatu's licenses on file in 2 states: California and New York.

Dmand AI lists back pain injection, drug use disorders, lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems and thoracic spine disorders among the conditions Dr. Qatu treats.

CMS data shows 1,180 Medicare services from Dr. Qatu across 16 procedure codes in 2024, for 427 Medicare patients. Medicare paid $91,980 for them.

CMS counts 427 Medicare patients who saw Dr. Qatu in 2024. The largest group is 65 to 74, with 177 patients. 75% of them have arthritis, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Qatu's median patient age at 64, with 62% women.

In 2024, Dr. Qatu wrote 381 Medicare Part D claims for 140 patients. 97% of them were for generic drugs. CMS names the drug for 300 of them, across 8 drugs with 11 or more claims each, at $6,397 in total drug cost. In 2023, CMS named 113 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Qatu for performance year 2024, reported as part of a group. Dr. Qatu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Qatu as offering telehealth.

Dmand AI links 5 papers to Dr. Qatu in 2017. 2017 was the busiest year, with 3. The most frequent topics are Fracture Fixation, Internal, Postoperative Complications and Tibial Fractures. Dr. Qatu has published most often in J Orthop Trauma. Dr. Qatu's most frequent co-authors are Kenneth A. Egol, MD, Sanjit R. Konda, MD and David N. Kugelman, MD.

CMS Open Payments shows 21 general payments to Dr. Qatu from 10 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 60% of the total. Abbott Laboratories paid the most, $1,189.

Dr. Qatu graduated from New York University School of Medicine in 2017.

Dr. Qatu is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.